NCT00967031 Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain Metastases Status COMPLETED Phase PHASE2
NCT00966706 Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00962312 Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00960544 Correlation of Genomic Variation in Enzymes Responsible for Metabolism of Capecitabine With Drug Metabolism Status WITHDRAWN Phase PHASE2
NCT00960349 Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients Status COMPLETED Phase PHASE1
NCT00960284 Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT00959946 Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00953537 Predicting Response to Capecitabine in Women With Metastatic Breast Cancer Status COMPLETED Phase NA
NCT00938470 Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Status COMPLETED Phase PHASE2
NCT00920868 XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib Status COMPLETED Phase PHASE1
NCT00909987 Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum Status COMPLETED Phase PHASE2
NCT00909402 A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas Status COMPLETED Phase PHASE1
NCT00891878 Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction Status COMPLETED Phase PHASE2
NCT00889187 Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00887822 A Study of Bevacizumab (Avastin) Versus Placebo in Combination With Capecitabine (Xeloda) and Cisplatin as First-Line Therapy for Advanced Gastric Cancer Status COMPLETED Phase PHASE3
NCT00885066 Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT00882310 A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00871273 Pharmacokinetic Study of Capecitabine After Total Gastrectomy for Stomach Adenocarcinoma Status TERMINATED Phase PHASE4
NCT00869570 External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE1/PHASE2